Collegium Pharmaceutical (COLL) EBITDA (2014 - 2026)
Collegium Pharmaceutical (COLL) EBITDA from Mar 31, 2014 to Mar 31, 2026. The TTM Collegium Pharmaceutical (COLL) EBITDA is $192M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Collegium Pharmaceutical (COLL) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +31.66% |
| 3 Years TTM | +39.58% |
| 5 Years TTM | +21.23% |
Annual EBITDA change of Collegium Pharmaceutical (COLL)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $31M | -82.94% |
| 2025 | $184M | +5.80% |
| 2024 | $174M | +1.93% |
| 2023 | $170M | +373.50% |
| 2022 | $36M | +85.95% |
| 2021 | $19M | -66.09% |
| 2020 | $57M | -348.05% |
| 2019 | -$23M | +17.39% |
| 2018 | -$20M | -73.80% |
| 2017 | -$75M | -19.89% |
| 2016 | -$93M | +249.40% |
| 2015 | -$27M | +52.97% |
| 2014 | -$17M | +10.14% |
| 2013 | -$16M | N/A |
Comparison Collegium Pharmaceutical (COLL) five years EBITDA CAGR with competitors
Collegium Pharmaceutical (COLL) five years EBITDA CAGR is 21.23%.